药物输送
细胞外小泡
胞外囊泡
微泡
靶向给药
药品
化学
纳米技术
细胞生物学
生物
药理学
材料科学
生物化学
基因
小RNA
作者
Pieter Vader,Emma A. Mol,Gerard Pasterkamp,Raymond M. Schiffelers
标识
DOI:10.1016/j.addr.2016.02.006
摘要
Extracellular vesicles (EVs) are cell-derived membrane vesicles, and represent an endogenous mechanism for intercellular communication. Since the discovery that EVs are capable of functionally transferring biological information, the potential use of EVs as drug delivery vehicles has gained considerable scientific interest. EVs may have multiple advantages over currently available drug delivery vehicles, such as their ability to overcome natural barriers, their intrinsic cell targeting properties, and stability in the circulation. However, therapeutic applications of EVs as drug delivery systems have been limited due to a lack of methods for scalable EV isolation and efficient drug loading. Furthermore, in order to achieve targeted drug delivery, their intrinsic cell targeting properties should be tuned through EV engineering. Here, we review and discuss recent progress and remaining challenges in the development of EVs as drug delivery vehicles.
科研通智能强力驱动
Strongly Powered by AbleSci AI